{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:29:21Z","timestamp":1790713761844,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.molmet.2019.08.020","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:23:19Z","timestamp":1567538599000},"page":"145-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Cuiqing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish","family":"Barve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2019.08.020_bib1","first-page":"9026","article-title":"Role of liver biopsy in nonalcoholic fatty liver disease","volume":"20","author":"Nalbantoglu","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.molmet.2019.08.020_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3945\/ajcn.114.086314","article-title":"Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis","volume":"100","author":"Chung","year":"2014","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.molmet.2019.08.020_bib3","first-page":"446","article-title":"Carbohydrate intake and nonalcoholic fatty liver disease","volume":"16","author":"Neuschwander-Tetri","year":"2013","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.molmet.2019.08.020_bib4","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/hep.26299","article-title":"Dietary fructose in nonalcoholic fatty liver disease","volume":"57","author":"Vos","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2019.08.020_bib5","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1038\/nutd.2016.7","article-title":"Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20\u201330 years","volume":"6","author":"DeChristopher","year":"2016","journal-title":"Nutrition & Diabetes"},{"key":"10.1016\/j.molmet.2019.08.020_bib6","first-page":"160","article-title":"Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey","volume":"10","author":"Vos","year":"2008","journal-title":"Medscape Journal of Medicine"},{"key":"10.1016\/j.molmet.2019.08.020_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1113\/jphysiol.2011.215731","article-title":"The role of fructose transporters in diseases linked to excessive fructose intake","volume":"591","author":"Douard","year":"2013","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.molmet.2019.08.020_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ejcn.2011.159","article-title":"Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight\/obese men and women","volume":"66","author":"Cox","year":"2012","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1016\/j.molmet.2019.08.020_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1743-7075-9-68","article-title":"Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight\/obese humans","volume":"9","author":"Cox","year":"2012","journal-title":"Nutrition & Metabolism (London)"},{"key":"10.1016\/j.molmet.2019.08.020_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S000711451000574X","article-title":"Effects of 4-week very-high-fructose\/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial","volume":"106","author":"Silbernagel","year":"2011","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.molmet.2019.08.020_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2019.08.020_bib12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1210\/jc.2008-2192","article-title":"Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses","volume":"94","author":"Teff","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.molmet.2019.08.020_bib13","first-page":"490","article-title":"Fructose and liver function \u2013 is this behind nonalcoholic liver disease?","volume":"18","author":"Jin","year":"2015","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1016\/j.molmet.2019.08.020_bib14","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2019.08.020_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000476069","article-title":"Effect of restriction of foods with high fructose corn syrup content on metabolic indices and fatty liver in obese children","volume":"10","author":"Ibarra-Reynoso","year":"2017","journal-title":"Obesity Facts"},{"key":"10.1016\/j.molmet.2019.08.020_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/nu9060555","article-title":"Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases","volume":"9","author":"Plaza-Diaz","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.molmet.2019.08.020_bib17","doi-asserted-by":"crossref","first-page":"45176","DOI":"10.1038\/srep45176","article-title":"Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia","volume":"7","author":"Xue","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2019.08.020_bib18","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: a review","volume":"23","author":"Singh","year":"2017","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.molmet.2019.08.020_bib19","doi-asserted-by":"crossref","first-page":"e80169","DOI":"10.1371\/journal.pone.0080169","article-title":"Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice","volume":"9","author":"Ritze","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2019.08.020_bib20","first-page":"129","article-title":"Probiotics and nonalcoholic fatty liver disease","volume":"5","author":"Eslamparast","year":"2013","journal-title":"Middle East Journal of Digestive Diseases"},{"key":"10.1016\/j.molmet.2019.08.020_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.metabol.2017.03.013","article-title":"Non-alcoholic fatty liver disease: an update with special focus on the role of gut microbiota","volume":"71","author":"Doulberis","year":"2017","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1016\/j.molmet.2019.08.020_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbrc.2009.09.109","article-title":"Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus","volume":"390","author":"Koo","year":"2009","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2019.08.020_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1507\/endocrj.K07E-110","article-title":"ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome","volume":"55","author":"Iizuka","year":"2008","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.molmet.2019.08.020_bib24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/db06-0200","article-title":"Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob\/ob mice","volume":"55","author":"Dentin","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2019.08.020_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmet.2016.11.008","article-title":"A\u00a0critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism","volume":"6","author":"Fisher","year":"2017","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.molmet.2019.08.020_bib26","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.febslet.2009.07.053","article-title":"Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes","volume":"583","author":"Iizuka","year":"2009","journal-title":"FEBS Letters"},{"key":"10.1016\/j.molmet.2019.08.020_bib27","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2019.08.020_bib28","doi-asserted-by":"crossref","first-page":"31026","DOI":"10.1038\/srep31026","article-title":"Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury","volume":"6","author":"Liu","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2019.08.020_bib29","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.ajpath.2011.08.039","article-title":"Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury","volume":"179","author":"Wang","year":"2011","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.molmet.2019.08.020_bib30","doi-asserted-by":"crossref","first-page":"G32","DOI":"10.1152\/ajpgi.00024.2012","article-title":"Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury","volume":"303","author":"Wang","year":"2012","journal-title":"American Journal of Physiology \u2013 Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.molmet.2019.08.020_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ab.2010.02.023","article-title":"Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"401","author":"Kasumov","year":"2010","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmet.2014.09.008","article-title":"Fructose ingestion acutely stimulates circulating FGF21 levels in humans","volume":"4","author":"Dushay","year":"2015","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.molmet.2019.08.020_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jnutbio.2014.10.016","article-title":"Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease","volume":"26","author":"Zhang","year":"2015","journal-title":"Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib34","doi-asserted-by":"crossref","first-page":"24899","DOI":"10.1074\/jbc.M804308200","article-title":"Regulation of nuclear import\/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation","volume":"283","author":"Sakiyama","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib35","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1073\/pnas.0730817100","article-title":"Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver","volume":"100","author":"Kabashima","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2019.08.020_bib36","doi-asserted-by":"crossref","first-page":"16539","DOI":"10.1021\/bi991646a","article-title":"Purification of porcine brain protein phosphatase 2A leucine carboxyl methyltransferase and cloning of the human homologue","volume":"38","author":"De Baere","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib37","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1182\/blood-2010-08-300772","article-title":"Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A","volume":"117","author":"Salas","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molmet.2019.08.020_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/JOE-17-0727","article-title":"FGF21 acts as a negative regulator of bile acid synthesis","volume":"237","author":"Chen","year":"2018","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.molmet.2019.08.020_bib39","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.27592","article-title":"Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression","volume":"61","author":"Nagahashi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2019.08.020_bib40","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1074\/jbc.M107895200","article-title":"Mechanism for fatty acid \u201csparing\u201d effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase","volume":"277","author":"Kawaguchi","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","article-title":"Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease","volume":"52","author":"Leamy","year":"2013","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.molmet.2019.08.020_bib42","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/jamainternmed.2016.5394","article-title":"Sugar industry and coronary heart disease research: a historical analysis of internal industry documents","volume":"176","author":"Kearns","year":"2016","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.molmet.2019.08.020_bib43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.molmet.2019.08.020_bib44","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.molmet.2019.08.020_bib45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1091\/mbc.e08-06-0566","article-title":"Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin","volume":"20","author":"Harten","year":"2009","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.molmet.2019.08.020_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"Galman","year":"2008","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2019.08.020_bib47","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2019.08.020_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/db11-0846","article-title":"Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3","volume":"61","author":"Li","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2019.08.020_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cmet.2015.12.003","article-title":"FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver","volume":"23","author":"von Holstein-Rathlou","year":"2016","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2019.08.020_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jnutbio.2017.07.010","article-title":"Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice","volume":"49","author":"Maekawa","year":"2017","journal-title":"Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmet.2019.08.020_bib52","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2019.08.020_bib53","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2019.08.020_bib54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bbrc.2015.07.058","article-title":"Ingestion of eicosapentaenoic acid in the early stage of social isolation reduces a fibroblast growth factor 21 resistant state independently of body weight in KKA(y) mice","volume":"464","author":"Nonogaki","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2019.08.020_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/en.2010-1262","article-title":"Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance","volume":"153","author":"Hale","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2019.08.020_bib56","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2019.08.020_bib57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/EC-16-0103","article-title":"LPS infusion suppresses serum FGF21 levels in healthy adult volunteers","volume":"6","author":"Lauritzen","year":"2017","journal-title":"Endocrine Connections"},{"key":"10.1016\/j.molmet.2019.08.020_bib58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jnutbio.2012.01.014","article-title":"Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model","volume":"24","author":"Wagnerberger","year":"2013","journal-title":"Journal of Nutritional Biochemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib59","doi-asserted-by":"crossref","first-page":"e0117851","DOI":"10.1371\/journal.pone.0117851","article-title":"Induction of peroxisomes by butyrate-producing probiotics","volume":"10","author":"Weng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2019.08.020_bib60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10409231003667500","article-title":"Genetic control of de novo lipogenesis: role in diet-induced obesity","volume":"45","author":"Strable","year":"2010","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"key":"10.1016\/j.molmet.2019.08.020_bib61","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2019.08.020_bib62","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib63","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1128\/MCB.24.19.8671-8680.2004","article-title":"Phosphorylation of C\/EBPbeta at a consensus extracellular signal-regulated kinase\/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes","volume":"24","author":"Park","year":"2004","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.molmet.2019.08.020_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1179\/135100004225005985","article-title":"Effects of PPARgamma ligands and C\/EBPbeta enhancer on expression of extracellular-superoxide dismutase","volume":"9","author":"Adachi","year":"2004","journal-title":"Redox Report: Communications in Free Radical Research"},{"key":"10.1016\/j.molmet.2019.08.020_bib65","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2019.08.020_bib66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2006.06.008","article-title":"Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis","volume":"4","author":"Uyeda","year":"2006","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2019.08.020_bib67","doi-asserted-by":"crossref","first-page":"921","DOI":"10.18388\/abp.2001_3858","article-title":"Protein phosphatase 2A: variety of forms and diversity of functions","volume":"48","author":"Lechward","year":"2001","journal-title":"Acta Biochimica Polonica"},{"key":"10.1016\/j.molmet.2019.08.020_bib68","doi-asserted-by":"crossref","first-page":"21008","DOI":"10.1074\/jbc.M116.739920","article-title":"Leucine carboxyl methyltransferase 1 (LCMT-1) methylates protein phosphatase 4 (PP4) and protein phosphatase 6 (PP6) and differentially regulates the stable formation of different PP4 holoenzymes","volume":"291","author":"Hwang","year":"2016","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib69","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/S0021-9258(18)42727-5","article-title":"Ceramide stimulates a cytosolic protein phosphatase","volume":"267","author":"Dobrowsky","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2019.08.020_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.molmet.2019.08.020_bib71","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2015.01.005","article-title":"Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway","volume":"25","author":"Yu","year":"2015","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.molmet.2019.08.020_bib72","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.molmet.2019.08.020_bib73","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/apt.12695","article-title":"Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis","volume":"39","author":"Bajaj","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.molmet.2019.08.020_bib74","doi-asserted-by":"crossref","first-page":"e53028","DOI":"10.1371\/journal.pone.0053028","article-title":"Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment","volume":"8","author":"Bull-Otterson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2019.08.020_bib75","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbrc.2016.03.107","article-title":"Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice","volume":"473","author":"Kim","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.molmet.2019.08.020_bib76","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3945\/jn.114.197723","article-title":"Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults","volume":"144","author":"Ferrario","year":"2014","journal-title":"Journal of Nutrition"},{"key":"10.1016\/j.molmet.2019.08.020_bib77","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nature Communications"},{"key":"10.1016\/j.molmet.2019.08.020_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metabolism"}],"updated-by":[{"DOI":"10.1016\/j.molmet.2020.100999","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000}}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877819306738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877819306738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:19:48Z","timestamp":1761956388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877819306738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":78,"alternative-id":["S2212877819306738"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2019.08.020","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2019.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}